TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/18/2023
Back to search
Official data from USPTO
CDS CLINICAL DIAGNOSTIC SOLUTIONS, INC.
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
44
Latest update
04/18/2023
Trademark type
Combined
Nice classes
5
Filing date
03/08/2011
Registration date
11/13/2012
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/13/2022
Last transaction
06/13/2022
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
04/22/1999
First use in commerce
07/13/1999
Drawing code
3
Owner type
03
Owner location
Plantation, FL, US
Examiner
YARD, JOHN
Law office
M60
Current location
GENERIC WEB UPDATE
Mark description
The mark consists of the letter "C" and the letter "D" combined to form the letter "S" with three small triangles all superimposed on two large triangles, all to the left of the words "CLINICAL DIAGNOSTIC SOLUTIONS, INC."
Holders and representatives
Holders
Clinical Diagnostic Solutions, Inc.
Representatives
Ronald N. Rosenwasser FRIEDMAN ROSENWASSER & GOLDBAUM PA
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
buffer reagentsdiluent reagentsstopping reagents for medical use; whole blood lyophilizing kits comprising individual containers of immunolyse reagentof fixative reagentof stabilizer reagent and of buffered saline solution for cell suspension preparation of whole blood and bone marrow aspirate studies for medical use; kits for calibrating and control of in vitro diagnostic electronic hematology analysis instruments comprising control reagents for medical use and vials of reference calibrator; kits for determining white blood cell differentiation in vitro diagnostic electronic hematology analysis instruments comprising individual containers of diluent reagentslytic reagentsenzymatic reagentsquench reagents and/or control reagents for medical use
Publications
History of USPTO decisions and trademark events.
44 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/18/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/18/2023
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
06/13/2022
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
06/13/2022
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
06/13/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/13/2022
E89R
TEAS SECTION 8 & 9 RECEIVED
01/14/2022
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
11/13/2021
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
04/15/2018
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
04/15/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/15/2018
E815
TEAS SECTION 8 & 15 RECEIVED
04/05/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/07/2017
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
11/13/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
11/13/2012
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/28/2012
PUBO
PUBLISHED FOR OPPOSITION
08/28/2012
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/08/2012
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
07/20/2012
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/19/2012
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/19/2012
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/19/2012
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
07/06/2012
RDX3
NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
05/25/2012
RDX1
ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
05/25/2012
RRDX
ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
05/25/2012
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/19/2012
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/19/2012
ALIE
ASSIGNED TO LIE
04/06/2012
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
03/27/2012
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
01/25/2012
GNFR
FINAL REFUSAL E-MAILED
01/25/2012
CNFR
FINAL REFUSAL WRITTEN
01/25/2012
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/09/2011
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/09/2011
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/09/2011
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/16/2011
GNRT
NON-FINAL ACTION E-MAILED
06/16/2011
CNRT
NON-FINAL ACTION WRITTEN
06/16/2011
DOCK
ASSIGNED TO EXAMINER
06/08/2011
MDSC
NOTICE OF DESIGN SEARCH CODE MAILED
03/12/2011
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/11/2011
NWAP
NEW APPLICATION ENTERED
03/11/2011
Continuous trademark protection
Get notified about every new filing that threatens CDS CLINICAL DIAGNOSTIC SOLUTIONS, INC. or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.